Emcure Pharma IPO GMP, Price, Date, Allotment

0

Last updated on July 11, 2024

Emcure Pharma IPO Subscription StatusEmcure Pharma IPO Allotment Status Emcure Pharma IPO Listing
Emcure Pharma IPO subscription status

Emcure Pharma IPO Description – Emcure Pharmaceuticals stands as a prominent Indian pharmaceutical entity, dedicated to the advancement, production, and global promotion of an extensive array of pharmaceutical products spanning various critical therapeutic domains. Functioning as a research and development (R&D) oriented enterprise, Emcure boasts a distinct product portfolio encompassing oral medications, injectables, and biotherapeutics. This diverse range has facilitated its market penetration into over 70 countries, establishing a robust presence in India, Europe, and Canada.

The company has been ranked 13th in domestic sales among pharmaceutical companies in India for MAT FY 2024 and 4th in market share in its covered markets for the same period. Additionally, it is the leading pharmaceutical company in gynecology and HIV antiviral therapeutic areas for the MAT FY 2024. As of 31 March 2024, the company had a team of 548 qualified scientists and five dedicated R&D facilities in India. In addition, as of the same date, Emcure Pharmaceuticals had been granted 220 patents had 30 pending patent applications in several countries, and had submitted 102 drug master files (DMFs) for APIs with the U.S. Food and Drug Administration (USFDA).

Emcure Pharmaceuticals has 13 manufacturing facilities across India. The company has witnessed substantial sales expansion in India over the recent years. Its sales in India accounted for 48.28% of the total revenue from operations during FY 2024.

Emcure Pharmaceuticals IPO

Promoters of Emcure Pharma – Satish Ramanlal Mehta, Sunil Rajanikant Mehta, Namita Vikas Thapar, and Samit Satish Mehta


Emcure Pharmaceuticals IPO Details

Emcure Pharma IPO Dates3 – 5 July 2024
Emcure Pharma Issue PriceINR 960 – 1,008 per share
(Employee Discount – INR 90 per share)
Fresh issueINR 800 crore
Offer For Sale1,14,28,839 shares (INR 1,097.17 – 1,152.03 crore)
Total IPO sizeINR 1,952.03 crore
Minimum bid (lot size)14 shares (INR 14,112)
Face Value INR 10 per share
Retail Allocation35%
Listing OnBSE, NSE

Emcure Pharma’s Financial Performance

 FY 2022FY 2023FY 2024
Revenue5,855.395,985.816,658.25
Expenses4,946.315,278.365,978.08
Net income702.56561.85527.58
Margin (%)12.009.397.92
Figures in INR Crores unless specified otherwise

Emcure Pharma IPO News


Emcure Pharma Valuations & Margins

FY 2022FY 2023FY 2024
(Pre Issue)
FY 2024
(Post-Issue)*
EPS36.5529.3627.4926.34
PE Ratio34.92 – 36.6636.44 – 38.26

FY 2022FY 2023FY 2024
RONW (%)33.3221.2716.87
NAV109.69138.03162.93
ROCE (%)29.6922.0119.37
EBITDA (%)23.5420.24 19.01
Debt/Equity0.990.830.67

Emcure Pharma IPO GMP Today (Daily Trend)

DateDay-wise IPO GMPKostakSubject to Sauda
9 July 20243603,900
8 July 20243654,100
6 July 20243553,900
5 July 20243203,500
4 July 20243103,500
3 July 20242823,300
2 July 20242753,200
1 July 20242602,900
29 June 20242503,000

Emcure Pharma IPO Objectives

  • Repayment and/ or prepayment of all or a portion of certain outstanding borrowings availed by the company – INR 600 crore
  • General corporate purposes

Emcure Pharma – Comparison With Listed Peers

CompanyPE ratioEPSRONW (%)NAVRevenue (Cr.)
Emcure
Pharmaceuticals
36.6627.4916.87162.936,658.25
Dr. Reddy’s
Laboratories
17.93334.5919.741,693.7528,011.10
Cipla Limited30.1051.0115.43330.7825,774.09
Alkem Laboratories33.86150.1917.41862.4612,667.58
Torrent
Pharmaceuticals
57.7448.9424.15202.5710,728.0
Mankind Pharma45.3047.6820.43233.7310,334.78
Abbott India47.43565.2832.481,740.715,848.91
J. B. Chemicals &
Pharmaceuticals
50.4935.6618.90188.373,484.18

Emcure Pharma IPO Dates & Listing Performance

IPO Opening Date3 July 2024
IPO Closing Date5 July 2024
Finalisation of Basis of Allotment8 July 2024
Initiation of refunds9 July 2024
Transfer of shares to demat accounts9 July 2024
Emcure Pharma IPO Listing Date10 July 2024
Opening Price on NSEINR 1,325.05 per share (up 31.45%)
Closing Price on NSEINR 1,359.15 per share (up 34.84%)

Emcure Pharma IPO Reviews – Subscribe or Avoid?

Ajcon Global – Subscribe
Anand Rathi – Subscribe
Axis Capital –
Antique Stock Broking –
Arihant Capital –
Ashika Research – Not rated
Asit C Mehta –
BP Wealth – Subscribe
Capital Market – Subscribe
Canara Bank Securities – Subscribe
Choice Broking – Subscribe
STOXBOX – Subscribe
Elite Wealth –
GCL Broking –
Geojit – Subscribe
GEPL Capital – Subscribe
Hem Securities – Subscribe
HENSEX Securities – Subscribe
Master Capital Services – Subscribe
Jainam Broking – Subscribe for long term
DR Choksey – Subscribe
SBI Securities – Subscribe for long term
Marwadi Financial – Subscribe
Mehta Equities – Subscribe for long term
Nirmal Bang – Subscribe
Reliance Securities – Subscribe
SMC Global – 2/5
Samco Securities – Subscribe for listing gains
Sushil Finance – Subscribe for medium term
Swastika Investmart – Subscribe
Ventura Securities – Subscribe


Emcure Pharma Offer Lead Manager

KOTAK MAHINDRA CAPITAL COMPANY LIMITED
27 BKC, 1st Floor, Plot no. C-27,
‘G’ Block, Bandra Kurla Complex,
Bandra (East), Mumbai 400 051
Phone: +91 22 4336 0000
Email: [email protected]
Website: www.investmentbank.kotak.com


Emcure Pharma Offer Registrar

Link Intime India Private Limited 
C-101, 1st Floor, 247 Park, Lal Bahadur Shastri Marg,
Vikhroli (West), Mumbai 400 083, Maharashtra, India
Phone: +91 810 811 4949
Email: [email protected]
Website: www.linkintime.co.in


Emcure Pharma Contact Details

EMCURE PHARMACEUTICALS LIMITED
Plot No. P-1 and P-2, IT-BT Park, Phase II,
M.I.D.C., Hinjawadi, Pune 411 057, Maharashtra
Phone: +91 20 3507 0033, +91 20 3507 0000
Email: [email protected]
Website: www.emcure.com


Emcure Pharma IPO FAQs

How many shares in Emcure Pharma IPO are reserved for HNIs and retail investors?

The investors’ portion for QIB – 50%, NII – 15%, and Retail – 35%.

How to apply in Emcure Public Offer?

The best way to apply in Emcure public offer is through Internet banking ASBA (know all about ASBA here). You can also apply online through your stock broker using UPI. If you prefer to make paper applications, fill up an offline IPO form and deposit the same to your broker.

What is Emcure Pharma IPO GMP today?

Emcure Pharma IPO GMP today is INR 360 per share.

What is Emcure IPO kostak rate today?

Emcure IPO kostak rate today is NA per application.

What is Emcure Pharma Subject to Sauda rate today?

Emcure Pharma Subject to Sauda rate today is INR 3,900 per application.

LEAVE A REPLY

Please enter your comment!
Please enter your name here